CORRECTING AND REPLACING: Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial ResultsAccesswire • 03/09/23
Biofrontera Inc. Reports Fourth Quarter and Record Full-year 2022 Financial ResultsAccesswire • 03/08/23
Biofrontera, Inc. to Present at the 35th Annual ROTH Conference on March 13, 2023Accesswire • 03/02/23
Biofrontera Inc. to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023Accesswire • 02/22/23
Biofrontera, Inc. to Present at Third Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 21st – 24th, 2023Accesswire • 02/15/23
Biofrontera Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Study Evaluating Ameluz(R)-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkAccesswire • 01/09/23
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2022Accesswire • 01/09/23
Biofrontera Inc. Announces Voting Results from 2022 Annual Meeting of StockholdersGlobeNewsWire • 12/16/22
Biofrontera Inc. to Participate in Benchmark's 11th Annual Discovery One-on-One Investor ConferenceGlobeNewsWire • 11/30/22
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK'S VIRTUAL NON-DEAL ROADSHOW SERIES ON WEDNESDAY, NOVEMBER 30, MONDAY, DECEMBER 5, FRIDAY, DECEMBER 9, AND MONDAY, DECEMBER 19 2022GlobeNewsWire • 11/28/22
Biofrontera to Launch Phase 3 Clinical Study Evaluating Ameluz®-PDT for the Treatment of Actinic Keratosis on the Extremities, Neck and TrunkGlobeNewsWire • 11/21/22
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business UpdateGlobeNewsWire • 11/14/22
Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022GlobeNewsWire • 11/10/22
Biofrontera Inc. Fully Exercises Recently Acquired Options to Purchase Shares of Biofrontera AGGlobeNewsWire • 11/08/22
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AGGlobeNewsWire • 10/31/22
Biofrontera Inc. to Present at the LD Micro Main Event XV Investor ConferenceGlobeNewsWire • 10/20/22
BIOFRONTERA INC. TO PARTICIPATE IN RENMARK'S VIRTUAL NON-DEAL ROADSHOW SERIES ON FRIDAY OCTOBER 14, AND TUESDAY OCTOBER 18, 2022GlobeNewsWire • 10/12/22
Biofrontera Inc. Announces Preliminary Product Revenues for the Third Quarter of 2022GlobeNewsWire • 10/05/22